BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cadoni G, Marinelli L, De Santis A, Romito A, Manna R, Ottaviani F. Sudden hearing loss in a patient hepatitis C virus (HCV) positive on therapy with alpha-interferon: a possible autoimmune-microvascular pathogenesis. J Laryngol Otol 1998;112:962-3. [PMID: 10211222 DOI: 10.1017/s0022215100142197] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Interferon alfa. Meyler's Side Effects of Drugs 2016. [DOI: 10.1016/b978-0-444-53717-1.00900-8] [Reference Citation Analysis]
2 Park GW, Park HY, Bang EK, Jo JH, Jeong MW, Oh SH. Sudden Deafness in a Patient with Chronic Hepatitis C Treated with Peginterferon and Ribavirin Combination Therapy. Korean J Med 2015;88:288. [DOI: 10.3904/kjm.2015.88.3.288] [Reference Citation Analysis]
3 Jain S, Midha V, Sood A. Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy. Indian J Gastroenterol 2011;30:239-40. [PMID: 21986854 DOI: 10.1007/s12664-011-0126-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
4 Shabana MI, Amer AR, Dabbous AO, Al-sunni AA. Hearing profile in hepatitis C virus patients under dual treatment with interferon and ribavirin. Audiological Medicine 2010;8:142-153. [DOI: 10.3109/1651386x.2010.515708] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 CYTOKINES AND CYTOKINE MODULATORS. Meyler's Side Effects of Drugs in Cancer and Immunology 2010. [DOI: 10.1016/b978-0-444-53267-1.50006-x] [Reference Citation Analysis]
6 ANTIVIRAL DRUGS, INCLUDING IMMUNOGLOBULINS AND INTERFERONS. Meyler's Side Effects of Antimicrobial Drugs 2010. [DOI: 10.1016/b978-0-444-53272-5.50006-6] [Reference Citation Analysis]
7 Kitada T, Narimatsu T, Yamaguchi S. Sudden hearing loss in a patient with chronic hepatitis C treated with pegylated interferon α2a and ribavirin. Kanzo 2009;50:371-376. [DOI: 10.2957/kanzo.50.371] [Reference Citation Analysis]
8 Elloumi H, Houissa F, Hadj NB, Gargouri D, Romani M, Kharrat J, Ghorbel A. Sudden hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment. World J Gastroenterol 2007; 13(40): 5411-5412 [PMID: 17879419 DOI: 10.3748/wjg.v13.i40.5411] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
9 Kartal ED, Alpat SN, Ozgunes I, Usluer G. Adverse effects of high-dose interferon-alpha-2a treatment for chronic hepatitis B. Adv Ther 2007;24:963-71. [PMID: 18029321 DOI: 10.1007/BF02877700] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
10 Akimov S, Adeyemi OM. Peginterferon-α 2a in the treatment of chronic hepatitis C. Future Virology 2006;1:689-701. [DOI: 10.2217/17460794.1.6.689] [Reference Citation Analysis]
11 Pompili M, Pizzolante F, Larocca LM, Covino M, Rapaccini GL, Gasbarrini G. Ischaemic jejunal vasculitis during treatment with pegylated interferon-alpha 2b and ribavirin for hepatitis C virus related cirrhosis. Dig Liver Dis 2006;38:352-4. [PMID: 16169782 DOI: 10.1016/j.dld.2005.07.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
12 Block F. Hörstörungen. Medikamentös induzierte neurologische und psychiatrische Störungen. [DOI: 10.1007/3-540-28604-7_16] [Reference Citation Analysis]
13 Interferon alfa. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions 2006. [DOI: 10.1016/b0-44-451005-2/00862-7] [Reference Citation Analysis]
14 Wong VK, Cheong-Lee C, Ford JAE, Yoshida EM. Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment: Outcome after resumption of therapy. World J Gastroenterol 2005; 11(34): 5392-5393 [PMID: 16149154 DOI: 10.3748/wjg.v11.i34.5392] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
15 Formann E, Stauber R, Denk DM, Jessner W, Zollner G, Munda-Steindl P, Gangl A, Ferenci P. Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirin. Am J Gastroenterol 2004;99:873-7. [PMID: 15128353 DOI: 10.1111/j.1572-0241.2004.30372.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
16 Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 2002;36:S237-44. [PMID: 12407599 DOI: 10.1053/jhep.2002.36810] [Cited by in Crossref: 64] [Cited by in F6Publishing: 205] [Article Influence: 3.0] [Reference Citation Analysis]
17 Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 2002;36:S237-44. [PMID: 12407599 DOI: 10.1053/jhep.2002.36810] [Cited by in Crossref: 331] [Cited by in F6Publishing: 295] [Article Influence: 15.8] [Reference Citation Analysis]